151 related articles for article (PubMed ID: 32589058)
1. Effects of ACEi and ARB on post-exercise hypotension induced by exercises conducted at different times of day in hypertensive men.
Brito LC; Azevêdo L; Peçanha T; Fecchio RY; Rezende RA; da Silva GV; Pio-Abreu A; Mion D; Halliwill JR; Forjaz CLM
Clin Exp Hypertens; 2020 Nov; 42(8):722-727. PubMed ID: 32589058
[TBL] [Abstract][Full Text] [Related]
2. Separate aftereffects of morning and evening exercise on ambulatory blood pressure in prehypertensive men.
Brito LC; Rezende RA; Mendes C; Silva-Junior ND; Tinucci T; Cipolla-Neto J; de Moraes Forjaz CL
J Sports Med Phys Fitness; 2018; 58(1-2):157-163. PubMed ID: 28222574
[TBL] [Abstract][Full Text] [Related]
3. Post-Exercise Hypotension and Its Mechanisms Differ after Morning and Evening Exercise: A Randomized Crossover Study.
de Brito LC; Rezende RA; da Silva Junior ND; Tinucci T; Casarini DE; Cipolla-Neto J; Forjaz CL
PLoS One; 2015; 10(7):e0132458. PubMed ID: 26186444
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
5. Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.
Ferrari P; Marti HP; Pfister M; Frey FJ
J Hypertens; 2002 Jan; 20(1):125-30. PubMed ID: 11791035
[TBL] [Abstract][Full Text] [Related]
6. Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time.
Moran C; Xie K; Poh S; Chew S; Beare R; Wang W; Callisaya M; Srikanth V
J Alzheimers Dis; 2019; 68(4):1479-1488. PubMed ID: 30909218
[TBL] [Abstract][Full Text] [Related]
7. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers (ACEI/ARB) are Associated with Improved Limb Salvage after Infrapopliteal Interventions for Critical Limb Ischemia.
Khan SZ; Montross B; Rivero M; Cherr GS; Harris LM; Dryjski ML; Dosluoglu HH
Ann Vasc Surg; 2020 Feb; 63():275-286. PubMed ID: 31626938
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
Hashimoto J; Hirayama H; Hanasawa T; Watabe D; Asayama K; Metoki H; Kikuya M; Ohkubo T; Totsune K; Imai Y
Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study).
AlJaroudi WA; Refaat MM; Habib RH; Al-Shaar L; Singh M; Gutmann R; Bloom HL; Dudley SC; Ellinor PT; Saba SF; Shalaby AA; Weiss R; McNamara DM; Halder I; London B;
Am J Cardiol; 2015 Apr; 115(7):924-31. PubMed ID: 25682436
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide.
Sata N; Tanaka Y; Suzuki S; Kamimura R; Mifune H; Nakamura K; Miyahara K; Arima T
Circ J; 2003 Dec; 67(12):1053-8. PubMed ID: 14639023
[TBL] [Abstract][Full Text] [Related]
12. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study.
Kario K; Hoshide S; Shimizu M; Yano Y; Eguchi K; Ishikawa J; Ishikawa S; Shimada K
J Hypertens; 2010 Jul; 28(7):1574-83. PubMed ID: 20404743
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
[TBL] [Abstract][Full Text] [Related]
14. Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.
Wawruch M; Slezakova V; Murin J; Luha J; Bozik M; Leitmann T; Kuzelova M; Shah R
Aging Clin Exp Res; 2014 Jun; 26(3):307-14. PubMed ID: 24781831
[TBL] [Abstract][Full Text] [Related]
15. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
Movilli E; Camerini C; Gaggia P; Zubani R; Cancarini G
Am J Nephrol; 2018; 48(2):79-86. PubMed ID: 30071530
[TBL] [Abstract][Full Text] [Related]
16. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Esnault VL; Ekhlas A; Nguyen JM; Moranne O
Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
[TBL] [Abstract][Full Text] [Related]
17. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
18. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F
Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hypertension with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and resting metabolic rate: A cross-sectional study.
Pedrianes-Martin PB; Martin-Rincon M; Morales-Alamo D; Perez-Suarez I; Perez-Valera M; Galvan-Alvarez V; Curtelin D; de Pablos-Velasco P; Calbet JAL
J Clin Hypertens (Greenwich); 2021 Dec; 23(12):2106-2114. PubMed ID: 34846787
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Timing of Fixed Dose Triple Antihypertensive Combinations on Ambulatory Blood Pressure Monitoring Parameters.
Ileri C; Dogan Z; Ozben B; Bircan L; Acet A; Sen T
Clin Exp Hypertens; 2023 Dec; 45(1):2224941. PubMed ID: 37337964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
